Latest Breaking News On - Dale wahlstrom - Page 1 : comparemela.com
Share:
Pelvital, a privately held medical device company that has developed Flyte™, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence, announced today that Ryan Willemsen has been appointed Chief Commercialization Officer.
In this role, Willemsen will be responsible for leading market adoption of Flyte, building a global sales and distribution capability, establishing operational infrastructure to scale the growth of Pelvital, and helping to assure the financial wellbeing of the company. With more than 14 years of medical technology leadership experience, including 8 years in pelvic health, Willemsen has excelled at developing new markets, bringing new products to market, and leading successful commercial organizations.
Norway
Minnesota
United-states
Ryan-willemsen
Dale-wahlstrom
Medtronic
Chief-commercialization
நோர்வே
மினசோட்டா
ஒன்றுபட்டது-மாநிலங்களில்
டேல்-வல்ஸ்ற்றோம்
மெதிடிறோனிக்
Pelvital Appoints Chief Commercial Officer
MINNEAPOLIS–(BUSINESS WIRE)–Pelvital, a privately held medical device company that has developed Flyte™, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence, announced today that Ryan Willemsen has been appointed Chief Commercialization Officer.
In this role, Willemsen will be responsible for leading market adoption of Flyte, building a global sales and distribution capability, establishing operational infrastructure to scale the growth of Pelvital, and helping to assure the financial wellbeing of the company. With more than 14 years of medical technology leadership experience, including 8 years in pelvic health, Willemsen has excelled at developing new markets, bringing new products to market, and leading successful commercial organizations.
Norway
Minnesota
United-states
Ryan-willemsen
Dale-wahlstrom
Medtronic
Chief-commercialization
நோர்வே
மினசோட்டா
ஒன்றுபட்டது-மாநிலங்களில்
டேல்-வல்ஸ்ற்றோம்
மெதிடிறோனிக்